Ankur Capital invests in biotech cos MyoWorks, D-Nome

Ankur Capital has invested in two biotech startups - MyoWorks, and D-Nome. Mumbai-based MyoWorks is experimenting with edible fundal mycelium-based 2D and 3D scaffolds that can mimic real tissue environments to help develop realistic lab-produced meat. Hyderabad-based D-Nome is developing a molecular diagnostic platform to detect infectious diseases such as tuberculosis, hepatitis B and C, HIV, HPV, UTIs, and cancers early.